AACE Current News
Click the titles to read the full news article.
State of AACE and Council/Committees/Task Forces Annual Reports
AACE Member Notice Re: Thyrogen
AACE and ACE learned today that Genzyme has issued a Dear Health Care Provider letter alerting physicians to the potential for inadvertent patient exposure to trace amounts of vancomycin during the delivery of parenteral Thyrogen....
AACE Issues Joint Statement of Principle with ADA, EASD, and TES
Call for Nominations - 2015 AACE Elections
STATEMENT FROM THE AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS RE: GROWTH HORMONE THERAPY AND STROKE
FDA RELEASED REQUIRED REMS SAFETY INFORMATION FOR TAZEUM
FDA Issues Changes To Rosiglitazone Risk Update And REMS Program Changes
AACE Past President speaks out on Endocrine Workforce Study
AACE Position Statement on Lifelong Learning
The AACE Board of Directors, at its meeting on May 12/13, 2014, adopted the following position statement regarding lifelong learning advocating for creating a new process of certification for the clinical endocrinologist:...
2014 Advanced Framework for a New Diagnosis of Obesity as a Chronic Disease
State of AACE and Council/Committees/Task Forces Annual Reports
World Medical Association (WMA) 8th Version of the Declaration of Helsinki – Ethical Principles for Medical Research Involving Human Subjects
Targeted eye care education urged for adults with diabetes
Ultrasound May Cut Thyroid Biopsy Rate
Certain characteristics of thyroid nodules identified on ultrasound can help predict the likelihood of cancer, and may also help determine if fine-needle aspiration biopsy can be deferred, a large, single-center study suggested....
Obese Kids Face Immediate Heart Risks
Childhood obesity not only increases the risk of cardiovascular disease in later life, but also is linked to cardiovascular damage before adulthood based on evidence published in the Journal of the American College of Cardiology....
Abbott Initiates Voluntary Recall of FreeStyle InsuLinx® Blood Glucose Meters in the United States
New Thyroid Awareness website launched
AACE EHR Survey 2012
In an effort to inform and educate our AACE members, as well as their clinical and administrative support staff, we have designed a survey to address the high points and low points you have encountered either as a current or prospective EHR user... ...
State of AACE and Council, Committees, Task Forces Annual Reports
FDA Approves Weight Management Drug Qsymia
AACE response to new proposed recommendations from USPSTF on calcium and vitamin D
AACE Guidelines for Management of Dyslipidemia and Prevention of Atherosclerosis Are Now Available
FDA MedWatch - Monthly Safety Labeling Changes
Delays in Medicare Reimbursement
AACE’s Socioeconomics & Member Advocacy Department has received several inquiries from the membership regarding delays they are experiencing in Medicare reimbursement. Three issues have been identified that may be impacting your office practice....
NEW!! AACE Lipid Guidelines Now Available
NEW!! AACE Lipid Guidelines Now Available. Each year, an estimated 785000 Americans will have a new coronary artery disease (CAD) event, and approximately 470000 will have a recurrent attack. CAD caused approximately 1 of every 6 deaths in the United Stat...
ASAP is Now Available for ABIM MOC/Credit!!!
The American College of Endocrinology Self Assessment Program (ASAP) was recently accepted as part of the American Board of Internal Medicine (ABIM) Maintenance of Certification (MOC) program. For more details on how to participate, please visit: http://a...
STOP THE MEDICARE MELTDOWN!
AACE is partnering with the Texas Medical Association (TMA) and several other state and specialty societies on a petition drive to permanently repeal the flawed Medicare Sustainable Growth Rate (SGR) physician payment formula. The petition calls on Congre...
AACE to participate in 2nd World Congress on Interventional Therapies for Type 2 Diabetes
AACE will participate in the 2nd World congress on Interventional Therapies for Type 2 Diabetes, scheduled to be held in New York, March 28-30, 2011. AACE will be represented by Dr. Jeffrey Mechanick who will serve as a ...
This is the official Call for Nominations for the Fellow-in-Training Representative
This is the official Call for Nominations for the Fellow-in-Training Representative on the American Association of Clinical Endocrinologists' (AACE) Board of Directors for the 2011-2012 Association year. This is an excellent opportunity to actively partic...
Joint Statement by AACE, The American Thyroid Association, The Endocrine Society, and the Society of Nuclear Medicine on radioactive precautions following radioactive iodine therapy
AACE Spotlight on Satellites - CME Credit Available!
The long awaited Institute of Medicine report on "Dietary Reference Intakes for Calcium and Vitamin D" was released November 30th and is available
The long awaited Institute of Medicine report on "Dietary Reference Intakes for Calcium and Vitamin D" was released November 30th and is available at http://www.iom.edu/Reports/2010/Dietary-Reference-Intakes-for-Calcium-and-Vitamin-D.aspx. Key features of...
Please Pay Your 2011 AACE Dues
Dues paying members of AACE should have received numerous emails and their dues invoice for 2011 in the mail. You may pay your dues securely online by visiting: http://www.aace.com/membership/dues.php or by using the invoice you were sent. Please check yo...
FDA Drug Safety Alert on Heart Medication Dronedarone (Multaq)
FDA is alerting healthcare professionals and patients about cases of rare, but severe liver injury, including two cases of acute liver failure leading to liver transplant in patients treated with the heart medication dronedarone (Multaq). Dronedarone is a...
Important Recall for Triad Group Alcohol Prep Pads Affects Genetech Pre-packaged Medicines
The FDA has issued a recall involving all lots of alcohol prep pads, alcohol swabs, and alcohol swabsticks manufactured by the Triad Group due to concerns about potential contamination with Bacillus cereus. An alert was recently released noting that Triad...
The FDA has issued a drug safety communication updating the public
The FDA has issued a drug safety communication updating the public about new labeling information which has been added to the physician labeling and patient labeling (Medication Guide) on the cardiovascular risks (including heart attack) of the dr...
FDA issues product safety alert:
FDA issues product safety alert: Triad lubricating jelly products may not be sterile. Patients who are immuno-compromised, such as those with diabetes, cancer and certain other chronic diseases, may be at potential risk for infection. They were distribute...
CMS issues instructions to Medicare Contractors to reprocess claims affected by The Affordable Care Act And 2010 Medicare Physician Fee Schedule Changes
On March 23, 2010, President Obama signed into law the Affordable Care Act. Various provisions of the new law were effective April 1, 2010, or earlier and, therefore, were implemented some time after their effective date. In addition, corrections to the...
AACE and the American Diabetes Association (ADA) issue a joint statement in response to American College of Physicians (ACP) clinical guidelines for inpatient glucose control.
FDA Joint Committee hearing scheduled for Friday, September 9 to discuss the benefits and risks of long-term bisphosphonate use
FDA Joint Committee hearing scheduled for Friday, September 9 to discuss the benefits and risks of long-term bisphosphonate use for the treatment and prevention of osteoporosis in light of the emergence of the safety concerns of osteonecrosis of the jaw a...
Information on potential shortage of Thyrogen
New study by the Institute for Alternative Futures
RADIATION RISKS TO HEALTH
The growing concern surrounding the release of radiation from an earthquake and tsunami-stricken nuclear complex in Japan has raised fears of radiation exposure to populations in North America from the potential plume of radioactivity crossing the Pacific...
AACE Releases New Clinical Practice Guidelines for Developing a Diabetes Mellitus Comprehensive Care Plan
AS HEARD ON RADIO: The Complete Guide to Lifelong Nutrition
FDA Issues Drug Safety Communication Containing An Updated Risk Evaluation and Mitigation Strategy Restricting Access to Avandia
LEGISLATIVE UPDATE - AACE is pleased to announce that the US House of Representatives and the US Senate have both introduced the “Preservation of Access to Osteoporosis Testing for Medicare Beneficiaries Act of 2011.”
This bill, sponsored by Representatives Michael Burgess (R-26th-TX) and Shelley Berkley (D-1st-NV) in the House, and by Senators Olympia Snowe (R-ME) and Debbie Stabenow (D-MI) in the Senate, would extend current Medicare payment rates for energy x-ray ab...
AACE Submits Comments on ACO Proposed Rules
FDA announces new safety recommendations for high-dose simvastatin
News On Actos
Recently, French and then German regulators have withdrawn approval for Actos therapy in type 2 diabetes owing to a small but significantly increased risk of urinary bladder cancer noted in 1 study in patients taking the drug for longer than 5 years. Japa...